about
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxationHuman Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human UrotheliumEndogenous urotensin II selectively modulates erectile function through eNOSInvolvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function.Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity.Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone.Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and renin angiotensin system.Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia.Hydrogen sulfide and erectile function: a novel therapeutic target.BPH/LUTS and ED: common pharmacological pathways for a common treatment.Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature.A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2.A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.An ex vivo standardized assay to measure human platelet cGMP.Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors.Platelet cyclic guanosine monophosphate as a biomarker of phosphodiesterase type 5 inhibitor efficacy in the treatment of erectile dysfunction: a randomized placebo-controlled study.Dexamethasone modulates hypotension induced by opioids in anaesthetised rats.New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat.Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney.Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum.N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.Hydrogen sulfide is involved in dexamethasone-induced hypertension in ratDry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymersHydrogen Sulfide-Induced Dual Vascular Effect Involves Arachidonic Acid Cascade in Rat Mesenteric Arterial BedUrotensin II: A Novel Target in Human Corpus CavernosumA new mouse model of Peyronie's disease: An increased expression of hypoxia-inducible factor-1 target genes during the development of penile changesA superoxide dismutase mimetic with catalase activity (EUK-8) reduces the organ injury in endotoxic shockL-cysteine/cystathionine-β-synthase-induced relaxation in mouse aorta involves a L-serine/sphingosine-1-phosphate/NO pathway
P50
Q24656291-253F5B4F-48BA-4FD3-8B23-E983D3A8B45DQ28547959-52F31893-681F-4F4C-88E5-6B90A4B0567FQ34154714-24B82A50-7365-4D9C-8221-AA3027C0C638Q34983511-330F2189-9977-492C-985F-DE05BFADDB21Q35045653-3EEB96BB-B8EC-45B8-B257-AB9519347735Q35204849-DC3F0A16-0491-469C-8C1F-44935476FFAEQ35581957-F2FB868A-F3E6-42E8-8538-93AD074786A2Q37204021-4A9412A8-38A1-49F7-A194-13EE00BC3CB8Q37862060-A25562F8-CE2B-4914-9D61-3CEEEADD23F5Q38123213-1D2A2193-63C8-433F-9235-876D582FDD5CQ38161511-7F6D73FB-914D-4DBF-8752-3421B596F50BQ38316293-79628617-1E65-499D-BDD7-38156805EAC4Q39853266-46596774-047F-4976-A949-51BBAD54EAF1Q41231309-25694B81-374E-4298-A805-3BF017E7FAE6Q41485526-B94F36E7-84FB-4975-B283-DCEEBC87F130Q42139903-94D85D0E-E243-40A3-9321-D618A2823B1CQ42492332-8ADD5349-F614-48E2-ABA5-02F29757CB58Q42510309-FA925276-1209-498C-AA4A-034B69A8BF59Q43271130-E9692F4C-7A00-4040-8D40-E09ABF23862AQ43791919-82AF8111-A6B2-426D-AE0C-16CB7635704BQ44114224-7923F909-FAAD-41BD-9605-49E7CDF482D3Q44366328-B09E2FC4-7778-4BC7-99B8-A01D1F9CEDA7Q44792173-B044B53E-024F-4D39-A46E-C4A6031AF80DQ45153798-24477E71-18F5-4C2C-AE6B-759BF08D7B56Q46047739-E8964E74-4545-488B-B911-D5EBDEFED673Q46761480-3ACC67AF-1BF1-4095-9055-DAAECB0B4722Q47854551-E1309607-89A1-4759-A53A-FDE2B5701742Q57718569-8E946637-4DF5-4E5E-9F05-51BD3B922C57Q57718573-3A4752E7-B8EE-40AD-AA42-F621D6ECEF67Q57718579-CDF80102-C207-46AC-8A97-765DD417880BQ57718582-EF9440AA-7007-45A0-A314-151F06B341D1Q57718590-9E8BAFDD-C7C4-48A1-91DF-21FC282D9B19Q73223413-92E958F9-D823-4998-8FF8-904957351B10Q92140989-3006ED3D-158D-4DDE-A32B-8CA4F0D54FAE
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-0992-6400
@en
name
Roberta d'Emmanuele Di Villa Bianca
@ast
Roberta d'Emmanuele Di Villa Bianca
@en
Roberta d'Emmanuele Di Villa Bianca
@es
Roberta d'Emmanuele Di Villa Bianca
@nl
type
label
Roberta d'Emmanuele Di Villa Bianca
@ast
Roberta d'Emmanuele Di Villa Bianca
@en
Roberta d'Emmanuele Di Villa Bianca
@es
Roberta d'Emmanuele Di Villa Bianca
@nl
prefLabel
Roberta d'Emmanuele Di Villa Bianca
@ast
Roberta d'Emmanuele Di Villa Bianca
@en
Roberta d'Emmanuele Di Villa Bianca
@es
Roberta d'Emmanuele Di Villa Bianca
@nl
P106
P1153
6508385775
P21
P31
P496
0000-0003-0992-6400